SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-15-003874
Filing Date
2015-11-02
Accepted
2015-11-02 16:17:01
Documents
1
Period of Report
2015-10-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT lytle_f4-103015.html 4  
1 OWNERSHIP DOCUMENT lytle_f4-103015.xml 4 3242
  Complete submission text file 0001019687-15-003874.txt   4656
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LYTLE PAUL J (Reporting) CIK: 0001244110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32839 | Film No.: 151190823